GFM
CGON icon

GF Fund Management’s CG Oncology CGON Stock Holding History

GF Fund Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$127K Sell
1,789
-23
-1% -$1.5K ﹤0.01% 309
2026
Q1 		$123K Buy
1,812
+227
+14% +$12.9K ﹤0.01% 322
2025
Q4 		$65.8K Sell
1,585
-55
-3% -$2.28K ﹤0.01% 382
2025
Q3 		$66.1K Sell
1,640
-91
-5% -$2.65K ﹤0.01% 368
2025
Q2 		$45K Hold
1,731
– – ﹤0.01% 425
2025
Q1 		$42.4K Buy
1,731
+311
+22% +$8.75K ﹤0.01% 437
2024
Q4 		$40.7K Buy
+1,420
New +$48.6K ﹤0.01% 411

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GF Fund Management's CGON Position: Q2 2026 in Review

GF Fund Management reduced its CG Oncology (CGON) stake by 1.3% in Q2 2026, selling an estimated $1.5K and leaving 1,789 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #309.

GF Fund Management first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • GF Fund Management held 1,789 shares of CG Oncology worth $127K as of Q2 2026.
  • GF Fund Management sold 23 CG Oncology shares in Q2 2026, an estimated $1.5K.
  • CG Oncology made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #309 holding.
  • GF Fund Management first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.